Survey on artificial hydration practices for terminal cancer patients in Taiwan
Exploring Indications and Practices of Administering Artificial Hydration to Terminal Cancer Patients and Establishing Clinical Consensus Guideline in Taiwan
National Taiwan University Hospital · NCT06329856
This study is trying to understand how doctors in Taiwan decide to use artificial hydration for patients with terminal cancer to help create better guidelines for care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1270 (estimated) |
| Sex | All |
| Sponsor | National Taiwan University Hospital (other) |
| Locations | 1 site (Taipei) |
| Trial ID | NCT06329856 on ClinicalTrials.gov |
What this trial studies
This study aims to explore the indications and practices of administering artificial hydration to terminal cancer patients in Taiwan through a nationwide survey of palliative care physicians. The researchers will develop a questionnaire based on literature reviews and clinical ethics principles, which will be validated and distributed to members of relevant medical societies. The goal is to gather insights that will help establish evidence-based consensus guidelines for physicians in Taiwan regarding artificial hydration in palliative care.
Who should consider this trial
Good fit: Ideal candidates for this study are palliative care physicians and oncology specialists in Taiwan with at least one year of experience in caring for terminally ill patients.
Not a fit: Patients without clinical experience in palliative care or those who decline to sign informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide clear guidelines for healthcare providers on the ethical administration of artificial hydration to improve the quality of care for terminal cancer patients.
How similar studies have performed: While there is limited research specifically on this topic in Taiwan, similar studies in other regions have successfully established guidelines for palliative care practices.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Taiwan Academy of Hospice Palliative Medicine * Taiwan Society of Cancer Palliative Medicine * At least a year in training to take care of terminally ill patients * Have signed informed consent. Exclusion Criteria: * No clinical experience in palliative care * Decline to sign informed consent
Where this trial is running
Taipei
- Department of Family Medicine, National Taiwan University Hospital — Taipei, Taiwan (RECRUITING)
Study contacts
- Study coordinator: Shao-Yi Cheng, MD,MSc,DrPH
- Email: scheng2140@gmail.com
- Phone: +886-2312-3456
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Terminal Cancer, Hospice, Palliative Medicine, Artificial hydration